▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #71 by analyst upside · 2026-06-27
SKYE
Skye Bioscience, Inc.
Healthcare · Market Cap $24M · P/E 0x
ANALYST PRICE TARGET
+1034.6%
implied upside to consensus target
Current Price $0.68
Consensus Target $7.71
Bull Target $20.0
Bear Target $2.0
Analysts Covering 7
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
4
Hold
2
Sell
0
52-Week Low $0.57
52-Week High $5.75
YTD Return -22.6%
FUNDAMENTALS
Market Cap $24M
P/E Ratio (TTM) N/A
Forward P/E -0.6x
EPS (TTM) $-1.45
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $0.57
52-Week High $5.75
Current Price $0.68
Bear Target $2.0
Bull Target $20.0
● Now $0.68 ● Target $7.71
TRADING DATA
Avg Volume 198K
YTD Return -22.6%
Analyst Count 7
Consensus Buy
Upside to Target +1034.6%
Last Updated 2026-06-27

ANALYST SUMMARY

Skye Bioscience, Inc. (SKYE) is currently trading at $0.68 with a Wall Street consensus price target of $7.71, implying potential upside of 1034.6% over the next 12 months. 7 analysts currently cover SKYE, with a consensus rating of Buy - 75% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $20.0, while the most cautious has a target of $2.0.

SKYE operates in the Healthcare sector with a market capitalisation of $24M. The stock is down 22.6% year-to-date and is currently trading near the lower end of its 52-week range of $0.57 – $5.75.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

PSTV +757.1%
Plus Therapeutics, Inc.
$29M · P/E 0.2x · Buy
DWTX +748.5%
Dogwood Therapeutics, Inc.
$55M · P/E 1.4x · Strong Buy
ETST +566.7%
Earth Science Tech, Inc.
$43M · P/E 15.0x · Hold
VXRT +488.2%
Vaxart, Inc.
$123M · P/E 3.2x · Buy
AGEN +411.6%
Agenus Inc.
$126M · P/E 1.4x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for SKYE, with each firm's 90-day track record across all stocks we track. See full firm rankings →

HC Wainwright & Co. ● Initiated
Buy 2025-09-30 31% win rate (48 calls)
Evercore ISI Group ● Initiated
Outperform 2025-08-15 Building track record
JMP Securities reit
Market Outperform → Market Outperform 2025-06-24 Building track record
Craig-Hallum — Reiterated
Buy → Buy 2025-03-21 Building track record
Citizens Capital Markets reit
Market Outperform → Market Outperform 2025-03-21 Building track record
William Blair ● Initiated
Outperform 2025-02-28 44% win rate (9 calls)
Scotiabank ● Initiated
Sector Outperform 2024-09-30 20% win rate (5 calls)
Piper Sandler reit
Overweight → Overweight 2024-09-20 14% win rate (7 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
30
out of 100
Coverage depth
16/30
Consensus clarity
0/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →